iANTHUS CAPITAL HOLDINGS (ITHUF) Total Non-Current Liabilities (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Total Non-Current Liabilities came in at $370.0 million in Q1 2026, up 11.47% year-on-year from $332.0 million in Q1 2025, and up 3.74% quarter-over-quarter from $356.7 million in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $370.0 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $370.0 million, up 11.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $370.0 million (up 11.47% YoY), and the FY2025 annual result was $356.7 million, up 6.97% from the prior year.
  • Total Non-Current Liabilities came in at $370.0 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $356.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $392.0 million in Q1 2022 to a low of $292.5 million in Q4 2022.
  • The 5-year median for Total Non-Current Liabilities is $339.1 million (2023), against an average of $335.4 million.
  • Peak annual rise in Total Non-Current Liabilities reached 16.88% in 2022, while the deepest fall reached 20.65% in 2022.
  • iANTHUS CAPITAL HOLDINGS's Total Non-Current Liabilities stood at $292.5 million in 2022, then rose by 15.93% to $339.1 million in 2023, then decreased by 1.66% to $333.5 million in 2024, then advanced by 6.97% to $356.7 million in 2025, then gained by 3.74% to $370.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $370.0 million (Q1 2026), $356.7 million (Q4 2025), and $342.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn 370.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 370.04 Mn
Dec 31, 2025 356.71 Mn
Sep 30, 2025 342.87 Mn
Jun 30, 2025 342.91 Mn
Mar 31, 2025 331.98 Mn
Dec 31, 2024 333.46 Mn
Dec 31, 2023 339.07 Mn
Dec 31, 2022 292.48 Mn
Sep 30, 2022 294.39 Mn
Jun 30, 2022 293.32 Mn
Mar 31, 2022 391.97 Mn
Dec 31, 2021 368.61 Mn
Sep 30, 2021 362.31 Mn
Jun 30, 2021 347.61 Mn
Mar 31, 2021 335.37 Mn
Dec 31, 2020 305.56 Mn